SCHEMBL16634858

SCHEMBL16634858

O=C(O)c1ccc(Nc2ccccc2[N+](=O)[O-])c(F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 3/20 0.63
AKR1C3 P42330 3/20 0.62
AKR1C2 P52895 3/20 0.62
MAPT P10636 7/20 0.60
ALDH1A1 P00352 2/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
KMT2A Q03164 7/20 0.58
MEN1 O00255 6/20 0.58
POLB P06746 1/20 0.58
MAPK1 P28482 1/20 0.51
CASP7 P55210 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
HPGD P15428 3/20 0.49
AKR1C4 P17516 2/20 0.49
AKR1C1 Q04828 2/20 0.49
AKR1B1 P15121 1/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
AR P10275 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16634860 1.00 HCAR3 (0.63) HCAR3AKR1C3AKR1C2MAPTALDH1A1
SCHEMBL27496168 0.90 AKR1C3 (0.56) HCAR3AKR1C3AKR1C2MAPTALDH1A1
SCHEMBL16634619 0.84 HCAR3 (0.53) HCAR3AKR1C3AKR1C2MAPTALDH1A1
SCHEMBL16634621 0.84 HCAR3 (0.53) HCAR3AKR1C3AKR1C2MAPTALDH1A1
SCHEMBL9537323 0.83 CASP6 (0.51) HCAR3MAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL16634569 0.82 KMT2A (0.57) HCAR3MAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL16634745 0.82 ALDH1A1 (0.54) HCAR3MAPTALDH1A1SMN1; SMN2KMT2A
SCHEMBL16634593 0.82 HCAR3 (0.57) HCAR3AKR1C3AKR1C2MAPTALDH1A1
SCHEMBL16634595 0.82 HCAR3 (0.57) HCAR3AKR1C3AKR1C2MAPTALDH1A1
SCHEMBL16634572 0.82 KMT2A (0.57) HCAR3MAPTALDH1A1SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015052675-A1 SUBSTITUTED DIHYDRO-BENZIMIDAZOLE COMPOUNDS AS ROR GAMMA MODULATORS GLENMARK PHARMACEUTICALS S.A. (CH) 2015-04-16 WO disclosed